全球蛋白质体学市场：特色见解（2024-2029）

预计2023年至2029年期间全球蛋白质体学市场规模的年复合成长率为 12.94%。

2024年，Thermo Fischer Scientific宣布收购 Olink Holding AB。 Olink 是开发下一代蛋白质体学解决方案的先驱。 Olink 致力于先进蛋白质体学的发现和开发，为学术机构和生物製药公司提供支援。

2023年，领先的资料驱动蛋白质体学技术公司 SomaLogic 和 Standard BioTools Inc. 宣布已达成最终协议，以全股票交易方式合併。

Danaher继续进行併购，于2023年以约 57亿美元收购了蛋白质体学市场的主要参与者之一 Abcam。 Abcam 提供科学研究的工具和试剂，包括诊断、药物发现和蛋白质体学。

2023年，Bruker Corporation与Biognosys AG宣布建立策略伙伴关係。根据合作关係，Biognosys 将在蛋白质组学和蛋白质基因组学合约研究服务领域处于领先地位，利用Bruker尖端的4D 蛋白质组学 timsTOF 技术进行精准蛋白质组学开发。

Agilent Technologies与 MRM Proteomics 签署了2022年新的联合行销协议。新协议目的是进一步提高定量蛋白质组学应用和代谢物分析的能力。

2021年，BGI将与Champions Oncology合作，提供基于质谱（MS）的多组学和蛋白质组学资料分析解决方案。

本报告研究了全球蛋白质体学市场，并提供了市场概述以及依产品、应用、最终用户和地区划分的趋势，以及参与市场的公司概况。

目录

第1章 蛋白质体学市场竞争格局概论

• 执行摘要
• 主要调查结果

第2章 蛋白质体学市场的竞争格局

• 全球蛋白质体学市场收入预测（2020-2029，十亿美元）

第3章 蛋白质体学市场展望与机会

• 蛋白质体学市场机会与趋势
• 蛋白质体学市场驱动因素
• 蛋白质体学市场限制

第4章 蛋白质体学市场细分资料

• 全球：依产品划分的预计收入（2020年至2029年，十亿美元）
• 全球：依应用划分的预测收入（2020年至2029年，十亿美元）
• 全球：依最终用户划分的收入预测（2020年至2029年，十亿美元）

第5章 主要地区概况

• 北美：蛋白质体学市场收入预测（2020-2029年，十亿美元）
  • 美国
  • 加拿大
• 欧洲：蛋白质体学市场收入预测（2020-2029年，十亿美元）
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
• 亚太地区：蛋白质体学市场收入预测（2020-2029年，十亿美元）
  • 日本
  • 中国
  • 韩国
  • 澳洲
  • 印度
• 拉丁美洲：蛋白质体学市场收入预测（2020-2029年，十亿美元）
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲：蛋白质体学市场收入预测（2020-2029年，十亿美元）
  • 土耳其
  • 南非
  • 沙乌地阿拉伯

第6章 蛋白质体学市场产业概览

• 蛋白质体学市场 – 竞争格局
• 蛋白质体学市场 - 主要供应商概况
• 蛋白质体学市场-其他主要供应商
• 蛋白质体学市场 - 主要策略建议

第7章 附录

The global proteomics market is expected to grow at a CAGR of 12.94% from 2023 to 2029.

RECENT VENDORS ACTIVITIES

• In 2024, Thermo Fischer Scientific announced the acquisition of Olink Holding AB. Olink -a pioneer company in next-generation proteomics solution development. Olinks' expertise lies in advanced proteomics discovery development, supporting both academic institutes and biopharma companies.
• In 2023, SomaLogic - one of the leading companies in data-driven proteomics technology, and Standard BioTools Inc., announced that they have entered into a definitive agreement to combine in an all-stock merger.
• Continuing a merger and acquisition streak, Danaher Acquired Abcam, one of the leading companies in the proteomics market to around USD 5.7 billion in 2023. Abcam offers tools and reagents for diagnostic, drug discovery, and scientific research including proteomics.
• In 2023, Bruker Corporation and Biognosys AG announced a strategic partnership. Under this partnership, Biognosys will lead proteomics and proteogenomic Contract Research Organization services and will access Bruker's leading 4D proteomics timsTOF technology for high-precision proteomics development.
• Agilent Technologies entered into a new co-marketing agreement with MRM Proteomics in 2022. This new agreement aimed to further improve the capabilities of quantitative proteomic applications and metabolite analysis.
• In 2021, BGI made a partnership with Champions Oncology company to offer Mass Spectroscopy (MS)- based multi-omics and proteomics data analysis solutions.

KEY TAKEAWAYS

• By Product: The consumables and reagents segment holds the largest market share of 76%. The segmental growth is due to consumables and reagents are emerging and crucial developments for developing new biomarkers and elucidating cellular processes.
• By Applications: The forensics & applied proteomics segment shows the highest growth of 14.31% as they offer a powerful approach to characterizing and identifying proteins for various applications
• By End-Users: The pharma & biotech companies segment holds the largest market share. The growing R&D and clinical trials to develop novel, targeted, and personalized medicines are accelerating the demand for proteomics research.
• By Geography: North America holds the largest share of the global proteomics market. The growth is attributed to the growing prevalence of chronic diseases and the associated demand for personalized medicine.
• Growth Factor: The global proteomics market is poised for growth, driven by advancements in proteomics technologies and a focus on high-throughput methods and related techniques.

MARKET DRIVERS & OPPORTUNITIES

Attention Towards High Throughput Proteomics and Associated Techniques

High Throughput Proteomics (HTP) refers to the use of high-capacity and automated analytical techniques to conduct large-scale protein analysis, such as protein quantification, identification, and characterization. The attention towards HTP, proteomics tools become more advanced in terms of speed and sensitivity. Recent developments in mass spectrometers with high speed, sensitivity, & precision, as new methods of sample preparation, data analysis, and interrogation are collectively supporting high-throughput proteomics. One such recent advancement is Data-independent Acquisition (DIA), which enables greater coverage and unbiased analysis of proteome. This new technology can help to identify the same set of proteins reproducibility across thousands of samples. Mass spectroscopy remains a cornerstone in the proteomic research field. Currently, high-throughput MS technologies are becoming more efficient and sophisticated. Also, these developments are expected to empower researchers and scientists to understand and analyze complex and new proteomics with higher accuracy, sensitivity, and high throughput, facilitating discoveries in drug development and biomarker identification.

Emerging Technologies and Methods in Proteomics Study

Recently, several new and promising avenues have improved the current method of proteomic potentially.Of these, the methods to monitor post-translation modification are one of the emerging trends in proteomics. In several real situations in the body, the protein concentration does not differ, but the function of the protein differs due to post-translation modification. The development of new methods to monitor post-translation modification (PTM) has the potential to lead to a deep understanding of the protein function.

Proteomics and Personalized Medicines

Personalized medicine or precision medicine is an emerging healthcare approach that takes into account an individual's molecular profile, genetics, lifestyle, and environment to predict essential and best treatment for patients. The rising focus on precision medicines drives the demand for proteomics studies. The proteomics field studies proteins and their characteristics, helping to develop and deliver personalized medicines. This approach promises improved efficacy, cost-effective healthcare, and reduced side effects by tailoring interventions to each patient's unique characteristics. In addition, from biomarker discovery to new drug development, proteomics offers a potential tool for personalized medicines.

INDUSTRY RESTRAINTS

Limitations in Accessing the Proteome

The proteome is dynamic, complex, and diverse in structure, composition, and number of variants than the genome or transcriptome. There are multiple processes to come to the proteome starting from the genome. The genome in humans consists of about 20,000 genes that by estimation give rise to about 1,000,000 or more variants of protein through the process of transcription and translation. Further, the number of processes modify these proteins chemically and give rise to a large number of protein variants with high diversity and structural variations through post-translational modifications. Thus, it is difficult to measure these protein variants with high diversity, complexity, and dynamic nature with traditional technologies. However, the existing proteomics methods can measure the breadth and depth of the proteome's complexity, rapidly and at a large scale.

SEGMENT INSIGHTS

INSIGHT BY PRODUCT TYPE

The global proteomics market by product type is segmented into consumables & reagents, instruments & software, and services. The consumables and reagents segment holds the largest market share of over 76% in 2023. Proteomics is a highly complex process, encompassing steps from sample extraction and preparation to protein analysis. It requires a significant amount of consumables and reagents. Consumables include depletion and enrichment kits, trays, and various tools, while reagents consist of buffers, detergents, salts, and reducing agents. Proteomic studies, ranging from small and medium-scale to large-scale, are regularly conducted in clinical diagnostics and drug discovery, driving demand for high-quality consumables and reagents. These studies often rely on mass spectrometry (MS). Due to the complexity of proteomics, there is no standardized method for protein sample preparation for MS, further increasing the need for diverse consumables and reagents. Most consumables and reagents are single-use and must be discarded after use, leading to a continuous demand. This ongoing requirement significantly drives growth in this segment.

By Product

• Consumables & Reagents
• Instrument & Software
• Services

INSIGHT BY APPLICATIONS

The global proteomics market by applications is categorized into drug discovery & development and translational research, clinical applications, and forensic and applied proteomics. The forensic and applied proteomics segment shows significant growth with the fastest-growing CAGR of 14.31% during the forecast period. Proteomics has transformed forensic science by enabling the characterization and identification of proteins for various applications. Using proteomics, postmortem bodily fluids, organs, and tissues can be analyzed for protein profiling, enhancing forensic autopsy and pathology investigations. In forensic science, the primary goal is to uphold the integrity of the criminal justice system. Proteins, which are intrinsic to biological evidence, are highly stable and abundant biomolecules in forensic samples. Their diverse population in biological evidence provides valuable chemical, biological, and genetic information for investigators. Historically, protein analysis has been used for identifying body fluids and tissues, determining species, and aiding in human identification.

By Applications

• Drug Discovery & Development and Translational Research
• Clinical Applications
• Forensic and Applied Proteomics

INSIGHT BY END-USERS

Based on the end-users, the pharma & biotech companies segment accounted for the largest share of the global proteomics market. Pharma and biotech companies are major contributors to the proteomics market. Growing R&D efforts and clinical trials aimed at developing novel, targeted, and personalized medicines are driving the demand for proteomics research. These industries extensively use proteomics technologies in R&D to develop proteomics-based reagents, instruments, and protein-based diagnostic and therapeutic kits. The importance of proteomics in the pharmaceutical industry is rapidly increasing, with biopharma companies shifting their focus from genomics to proteomics. Proteomic studies offer significant opportunities in drug discovery, biomarker identification, personalized medicine development, and other applications. They have become the gold standard in drug discovery and development, providing comprehensive insights into cellular processes and enabling the development of targeted therapies.

By End-users

• Pharma & Biotech Companies
• Academic & Research Institutes/Laboratories
• Hospitals
• Diagnostics Labs and Forensic Labs

GEOGRAPHICAL ANALYSIS

North America leads the global proteomics market, driven by the growing prevalence of chronic diseases, increasing demand for personalized medicine, rising healthcare expenditure, and government funding for R&D. Chronic conditions such as cardiovascular diseases, genetic disorders, cancer, diabetes, and infectious diseases-major causes of death in the region-further fuel the adoption of personalized medicine and proteomics research.

The Asia-Pacific (APAC) region holds the third-largest market share but is expected to show the highest growth during the forecast period. This growth is propelled by the rapid expansion of life sciences industries, advancements in healthcare, increased R&D activities, and rising focus on personalized medicine. Healthcare spending in APAC has advanced clinical research and care, with health expenditure in 2021 accounting for 4% of GDP in low-income countries, 4.3% in lower-middle-income countries, and 7.6% in upper-middle- and high-income countries. Key countries such as Japan, China, India, and South Korea are driving demand for personalized care, accelerating proteomics studies in the development of personalized medicines.

By Geography

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
• APAC
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Turkey
  • South Africa
  • Saudi Arabia

COMPETITIVE LANDSCAPE

The global proteomics market report consists of exclusive data on 37 vendors. The market is highly competitive. There are several leading, growing, and emerging market players are present across the global market. Some emerging players compete against large and small medium-sized market players. Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific, Danaher, PerkinElmer, and BGI Group are some of the leading companies that accounted for major market share in the global proteomics market. These vendors are continuously focusing on expanding their proteomics solutions and services that meet client's requirements and international regulations, as well as increasing the efficiency of their products, and strengthening their market position.

Key Vendors

• Agilent Technologies
• Bio-Rad Laboratories
• Thermo Fisher Scientific
• Danaher
• PerkinElmer
• BGI Group

Other Prominent Vendors

• Bruker
• DiaSorin
• HORIBA
• Illumina
• INOVIQ
• LI-COR Biosciences
• Nautilus Biotechnology
• Proteome Factory
• QIAGEN
• Rhythm Biosciences
• Shimadzu Scientific Instruments
• Seer
• Waters
• Charles River Laboratories
• Applied Biomics
• Creative Proteomics
• Poochon Scientific
• SomaLogic
• Vproteomics
• AnteoTech
• Biognosys
• GeNei
• Grace Bio-Labs
• ITSI-BIO
• MSAID
• Olink
• Proteomics International
• Quanterix
• Alamar Biosciences
• Nicoya Lifesciences
• Promega

KEY QUESTIONS ANSWERED:

1. How big is the global proteomics market?

2. What are the factors driving the global proteomics market growth?

3. What is the growth rate of the global proteomics market?

4. Who are the major players in the global proteomics market?

5. Which region will have the highest growth in the global proteomics market?

TABLE OF CONTENTS

CHAPTER - 1:

• Competitive Landscape of Proteomics Market Overview
• Executive Summary
• Key Findings

CHAPTER - 2:

• Competitive Landscape of Proteomics Market
• GLOBAL: Projected Revenue of Proteomics Market (2020-2029; $ Billions)

CHAPTER - 3: Proteomics Market Prospects & Opportunities

• Proteomics Market Opportunities & Trends
• Proteomics Market Drivers
• Proteomics Market Constraints

CHAPTER - 4:Proteomics Market Segmentation Data

• Global: Projected Revenue by Product (2020-2029; $ Billions)
  • Consumables & Reagents
  • Instrument & Software
  • Services
• Global: Projected Revenue by Applications (2020-2029; $ Billions)
  • Drug Discovery & Development and Translational Research
  • Clinical Applications (Diagnostics applications)
  • Forensics & Applied proteomics (Other applications)
• Global: Projected Revenue by End-user (2020-2029; $ Billions)
  • Pharma & Biotech companies
  • Academic & Research Institutes/Laboratories
  • Hospitals
  • Diagnostic Labs & Forensic Labs

CHAPTER - 5: Key Regions Overview

• North America: Projected Revenue of Proteomics Market (2020-2029; $ Billions)
  • Projected Revenue of the Proteomics Market in the US
  • Projected Revenue of the Proteomics Market in Canada
• Europe: Projected Revenue of Proteomics Market (2020-2029; $ Billions)
  • Projected Revenue of the Proteomics Market in Germany
  • Projected Revenue of the Proteomics Market in the UK
  • Projected Revenue of the Proteomics Market in France
  • Projected Revenue of the Proteomics Market in Spain
  • Projected Revenue of the Proteomics Market in Italy
• APAC: Projected Revenue of Proteomics Market (2020-2029; $ Billions)
  • Projected Revenue of the Proteomics Market in Japan
  • Projected Revenue of the Proteomics Market in China
  • Projected Revenue of the Proteomics Market in South Korea
  • Projected Revenue of the Proteomics Market in Australia
  • Projected Revenue of the Proteomics Market in India
• Latin America: Projected Revenue of Proteomics Market (2020-2029; $ Billions)
  • Projected Revenue of the Proteomics Market in Brazil
  • Projected Revenue of the Proteomics Market in Mexico
  • Projected Revenue of the Proteomics Market in Argentina
• Middle East & Africa: Projected Revenue of Proteomics Market (2020-2029; $ Billions)
  • Projected Revenue of the Proteomics Market in Turkey
  • Projected Revenue of the Proteomics Market in South Africa
  • Projected Revenue of the Proteomics Market in Saudi Arabia

CHAPTER - 6: Proteomics Market Industry Overview

• Proteomics Market - Competitive Landscape
• Proteomics Market- Key Vendor Profiles
• Proteomics Market- Other Prominent Vendors
• Proteomics Market - Key Strategic Recommendations

CHAPTER - 7: Appendix

• Research Methodology
• Abbreviations
• About Arizton

LIST OF EXHIBITS

• Exhibit 1: Projected Revenues of Global Proteomics Market (2020 - 2029; $ BN)
• Exhibit 2: Market Size & Forecast - Consumables & Reagent (2020 - 2029; $ BN)
• Exhibit 3: Market Size & Forecast - Instrument & Software (2020 - 2029; $ BN)
• Exhibit 4: Market Size & Forecast - Services (2020 - 2029; $ BN)
• Exhibit 5: Market Size & Forecast - Drug Discovery & Development and Translation Research (2020 - 2029; $ BN)
• Exhibit 6: Market Size & Forecast - Clinical Applications (2020 - 2029; $ BN)
• Exhibit 7: Market Size & Forecast - Forensic and Applied Proteomics (2020 - 2029; $ BN)
• Exhibit 8: Market Size & Forecast - Pharma & Biotech Companies (2020 - 2029; $ BN)
• Exhibit 9: Market Size & Forecast - Academic/Research Institutes/Laboratories (2020 - 2029; $ BN)
• Exhibit 10: Market Size & Forecast - Hospitals (2020 - 2029; $ BN)
• Exhibit 11: Market Size & Forecast - Diagnostics Labs & Forensic Labs (2020 - 2029; $ BN)
• Exhibit 12: Projected Revenues of Proteomics Market in North America (2020 - 2029; $ BN)
• Exhibit 13: Projected Revenues of Proteomics Market in the US (2020 - 2029; $ BN)
• Exhibit 14: Projected Revenues of Proteomics Market in Canada (2020 - 2029; $ BN)
• Exhibit 15: Projected Revenues of Proteomics Market in Europe (2020 - 2029; $ BN)
• Exhibit 16: Projected Revenues of Proteomics Market in Germany (2020 - 2029; $ BN)
• Exhibit 17: Projected Revenues of Proteomics Market in the UK (2020 - 2029; $ BN)
• Exhibit 18: Projected Revenues of Proteomics Market in France (2020 - 2029; $ BN)
• Exhibit 19: Projected Revenues of Proteomics Market in Spain (2020 - 2029; $ BN)
• Exhibit 20: Projected Revenues of Proteomics Market in Italy (2020 - 2029; $ BN)
• Exhibit 21: Projected Revenues of Proteomics Market in APAC (2020 - 2029; $ BN)
• Exhibit 22: Projected Revenues of Proteomics Market in Japan (2020 - 2029; $ BN)
• Exhibit 23: Projected Revenues of Proteomics Market in China (2020 - 2029; $ BN)
• Exhibit 24: Projected Revenues of Proteomics Market in South Korea (2020 - 2029; $ BN)
• Exhibit 25: Projected Revenues of Proteomics Market in Australia (2020 - 2029; $ BN)
• Exhibit 26: Projected Revenues of Proteomics Market in India (2020 - 2029; $ BN)
• Exhibit 27: Projected Revenues of Proteomics Market in Latin America (2020 - 2029; $ BN)
• Exhibit 28: Projected Revenues of Proteomics Market in Brazil (2020 - 2029; $ BN)
• Exhibit 29: Projected Revenues of Proteomics Market in Mexico (2020 - 2029; $ BN)
• Exhibit 30: Projected Revenues of Proteomics Market in Argentina (2020 - 2029; $ BN)
• Exhibit 31: Projected Revenues of Proteomics Market in MEA (2020 - 2029; $ BN)
• Exhibit 32: Projected Revenues of Proteomics Market in Turkey (2020 - 2029; $ BN)
• Exhibit 33: Projected Revenues of Proteomics Market in the South Africa (2020 - 2029; $ BN)
• Exhibit 34: Projected Revenues of Proteomics Market in Saudi Arabia (2020 - 2029; $ BN)

LIST OF TABLES

• Table 1: Projected Revenues of Global Proteomics Market (2020 - 2029; $ BN)
• Table 2: Market Size & Forecast - Product (2020 - 2029; $ BN)
• Table 3: Market Size & Forecast - Product 2020 - 2029; (%)
• Table 4: Market Size & Forecast - Application (2020 - 2029; $ BN)
• Table 5: Market Size & Forecast - Application - 2029; (%)
• Table 6: Market Size & Forecast - End-user (2020 - 2029; $ BN)
• Table 7: Market Size & Forecast - End-user 2020 - 2029; (%)
• Table 8: Market Size & Forecast - Geography (2020 - 2029, $ BN)
• Table 9: Market Size & Forecast - Geography 2020-2029, (%)